Takeda Ventures, Inc. is the corporate venture capital group of Takeda, founded in 2001. The firm focuses on generating disruptive technologies and therapeutic solutions through venture-based investments in early-stage, preclinical opportunities and products that complement Takeda’s pipeline. They aim to partner with academic innovators, entrepreneurs, and venture investors to create a portfolio aligned with Takeda’s R&D pillars, including Oncology, Rare Genetics & Hematology, Neuroscience and Gastrointestinal and Inflammation.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions